RUNX2 and neoplasm: In a TNBC-PDX Br-001 model, RUNX2 expression was positive during continuous passage from P1 to P3 (Supplementary Figure 8C), and a significant decrease of tumor volume was observed in the CADD522-injected Br-001-bearing athymic mice (10 mg/kg, i.p).